key: cord-0982873-7slh77ya
authors: Moghimi, Minoosh; Moghtader, Amirhossein; Jozpanahi, Manijeh; Khodadadi, Kasra; Jafarzade, Mohammad; Abbaspour, Zahra
title: Correlation between CSF biomarkers and COVID-19 meningoencephalitis: A case series
date: 2020-12-31
journal: Respir Med Case Rep
DOI: 10.1016/j.rmcr.2020.101335
sha: efa81b33485cb6700ae5def48e28359878856acf
doc_id: 982873
cord_uid: 7slh77ya

BACKGROUND: Recent studies have focused on the incidence rate and pattern of meningoencephalitis in the coronavirus disease 2019 (COVID-19). AIM: This study aims to shed more light on the CSF pattern and clinical characteristics of meningoencephalitis COVID-19 patients in Zanjan, Iran. METHODS: Nine cases of laboratory and imaging confirmed COVID-19 were admitted to Valiasr Hospitals in Zanjan, Iran. Data were collected from 20 May 2020 to 20 June 2020. RESULTS: All the nine patients had positive RT-PCR COVID-19 and Pulmonary involvement who underwent Lumbar puncture and analysis, but despite neurological symptoms, the RT-PCR of CSF for COVID-19 was negative. CONCLUSION: Although we did not have any cases of positive RT-PCR for COVID-19 in lumbar puncture specimens, the justification of neurological symptoms in patients can be the transient presence of the virus in the CSF, and inflammation or autoimmune response caused by the virus, so more studies are needed to determine the cause of neurogenic symptoms.

Studies carried out since the COVID-19 outbreak have revealed conflicting statistics on the incidence of meningoencephalitis in various countries. In one national registry of 125 patients with COVID-19 and neurological or psychiatric disease reported over a 3-week period, 31% patients had altered mental status, which included 13% with encephalopathy (of whom 6% had encephalitis) [ The characteristics of the other six patients are listed in the tables . All patients' cultures were negative. CSF sample for herpes virus and tuberculosis was also negative. Brain CT scan showed generalized atrophy, and only small vessel disease was reported in Brain-MRI [4] .

RT-PCR performed on cerebrospinal fluid for COVID-19 was negative. None of the patients had CSF pleocytosis (WBC ≤3 cells/μL) (except number 9 patient): glucose and protein level are shown in Table 2 .

In our study, the most common clinical symptom of patients was a decrease in level of consciousness (50% in four patients). In some other studies, the most common clinical sign was dizziness [2, 5] . Examination of patients' CSF sugar level revealed that two patients had abnormal CSF sugar. One patient had 60 count leukocytes in the CSF, which was reported to be negative for other viral and bacterial causes, but for other patients, other viral causes were not investigated due to the lack of leukocytes in the CSF. In the Eden et al report, the CSF WBC count of six patients with COVID-19 and neurological symptoms was normal in all participants (WBC<3) [6] . RT-PCR performed on CSF of patients for COVID 19 was J o u r n a l P r e -p r o o f negative. Likewise, a definitive diagnosis of viral encephalitis depends on the ability to detect or culture the virus from CSF or brain tissue, but this can be difficult as SARS-CoV-2 is transiently disseminated and its titer in CSF can be low [7, 8] . This may indicate the absence of the virus in the CSF or the lack of detection of the virus in the CSF by RT-PCR. Even if a direct viral origin cannot be eliminated, the pathophysiology of brain damage related to SARS-COV-2 seems rather to involve an inflammatory or autoimmune response [9] . In the Eden study , SARS-CoV-2 RNA was detectable in plasma in 2 patients and CSF in 3 patients.

Due to these low levels of viral detection, all plasma and CSF samples with detectable viral RNA were reanalyzed using the Xpert® assay. Both reruns in plasma confirmed SARS-CoV-presence of the virus in the CSF, and inflammation or autoimmune response caused by the virus. Therefore, more studies are needed to determine the cause of neurogenic symptoms.

Moghtader, Jozpanahi, Moghimi, Khodadadi, Jafarzade and Abbaspour have equally contributed in designing, reviewing, drafting, analyzing the data and writing the manuscript.

There are no conflicts of interest.

No Funding J o u r n a l P r e -p r o o f 

UK-wide surveillance of neurological and neuropsychiatric complications of COVID-19: the first 153 patients

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan

Nervous system involvement after infection with COVID-19 and other coronaviruses

Case Report of 78-year-old man with meningitis, Pulmonary Thromboembolism & SARS-Coronavirus-2 infection

Lifting the mask on neurological manifestations of COVID-19

CSF biomarkers in patients with COVID-19 and neurological symptoms: A case series

Meningoencephalitis from SARS-CoV-2 infection

Encephalitis as a clinical manifestation of COVID-19

Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study